“…Multiple meta‐analysis have reported that AGT M235T is associated with heart failure (Imen et al, 2015; Jiang, He, & Yang, 2014), MI (Liang et al, 2013; Raygan, Karimian, Rezaeian, Bahmani, & Behjati, 2016; Sui & Gao, 2013), cardiomyopathy (Rani et al, 2017; J. L. Yao et al, 2015), and atrial fibrillation (H. Wang et al, 2015) while AGT T174M is connected to the high risk of MI (Hu, Wang, Pang, & Wang, 2015), hypertension (Liao et al, 2014), and atherosclerosis (W. Z. Wang, 2013). In addition, some other AGT gene polymorphisms including G217A and A20C are linked to hypertension (R. Yao et al, 2015; Zeng, Wang, Fang, Zhuang, & Fan, 2015). All these studies have provided the potential insights that genetic variation of AGT can contribute to various cardiovascular diseases.…”